Entrada Therapeutics Inc（TRDA）價格預測TRDAEntrada Therapeutics Inc

Alphio's TRDA stock price prediction model matches the current Entrada Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.51 (-0.16%). The 1-week path is $4.51 (-0.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Entrada Therapeutics Inc is not a strong buy right now due to significant financial losses and declining revenues. The current price is $5.11, and the company reported a net loss of $42.76 million for Q2 2026, indicating ongoing financial struggles. Additionally, insider selling has increased by 1842.13% over the last month, suggesting a lack of confidence from company insiders. The RSI is at 60.02, indicating a neutral momentum, but the forward P/E ratio is extremely high at 3333.33, reflecting uncertainty about future earnings. The main risk is the company's declining cash reserves, which fell from $295.7 million to $223 million in just six months, indicating tightening operational cash flow.

Entrada Therapeutics Inc (TRDA) last closed at $4.52, losing -10.67%. These facts feed the 1-day and 1-week TRDA price prediction above.